Interestingly, miR-124-3p targets the 3’UTR of Rab27a, reducing exosome secretion and inhibiting the PI3K/AKT signaling pathway, thereby curtailing NSCLC metastasis (55). Here, AKT1 is linked to non-small cell lung carcinoma.